| 1 | Cancer and Overgrowth Manifestations of PTEN Hamartoma Tumour Syndrome: Management Recommendations from the International PHTS Consensus Guidelines Working Group | 4.8 | 19 | Citations (PDF) |
| 2 | Exome-based cancer predisposition gene testing can provide a genetic diagnosis for individuals with heterogeneous tumor phenotypes | 2.4 | 3 | Citations (PDF) |
| 3 | Exploring MRI and Mammography Lesion Features for Breast Cancer Detection in PTEN Hamartoma Tumor Syndrome | 2.9 | 1 | Citations (PDF) |
| 4 | Deep Phenotyping of Pathology-Confirmed Benign Lesions in PTEN Hamartoma Tumor Syndrome Patients | 1.6 | 1 | Citations (PDF) |
| 5 | The continued ageing of people with AIDS in Italy: recent trend from the national AIDS Registry. | 1.0 | 0 | Citations (PDF) |
| 6 | Lifestyle Factors and Breast Cancer in Females with PTEN Hamartoma Tumor Syndrome (PHTS) | 2.9 | 3 | Citations (PDF) |
| 7 | Exploring the Prevalence of Oral Features for Early Detection of PTEN Hamartoma Tumour Syndrome | 0.7 | 3 | Citations (PDF) |
| 8 | Neuropsychological functioning of adults with PTEN hamartoma tumor syndrome | 1.1 | 2 | Citations (PDF) |
| 9 | The genomic landscape of breast and non-breast cancers from individuals with germline CHEK2 deficiency. | 2.4 | 4 | Citations (PDF) |
| 10 | Histopathological phenotyping of cancers in PTEN Hamartoma Tumor Syndrome for improved recognition: A single-center study | 2.9 | 4 | Citations (PDF) |
| 11 | Optimizing the detection of hereditary predisposition in women with epithelial ovarian cancer: nationwide implementation of the Tumor-First workflow | 1.3 | 6 | Citations (PDF) |
| 12 | Genomic instability in non–breast or ovarian malignancies of individuals with germline pathogenic variants in BRCA1/2 | 3.4 | 7 | Citations (PDF) |
| 13 | Increased frequency of infections and autoimmune disease in adults with Hamartoma Tumour Syndrome | 1.3 | 4 | Citations (PDF) |
| 14 | Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome. | 3.4 | 52 | Citations (PDF) |
| 15 | Microsatellite instability in noncolorectal and nonendometrial malignancies in patients with Lynch syndrome. | 3.4 | 18 | Citations (PDF) |
| 16 | Yield of annual endometrial cancer surveillance in women with Hamartoma Tumor Syndrome | 1.3 | 8 | Citations (PDF) |
| 17 | The most efficient and effective BRCA1/2 testing strategy in epithelial ovarian cancer: Tumor-First or Germline-First? | 2.4 | 11 | Citations (PDF) |
| 18 | Probability of detecting germline BRCA1/2 pathogenic variants in histological subtypes of ovarian carcinoma. A meta-analysis. | 2.4 | 36 | Citations (PDF) |
| 19 | Genetic Cancer Susceptibility in Adolescents and Adults 25 Years or Younger With Colorectal Cancer | 7.4 | 3 | Citations (PDF) |
| 20 | Gastric cancer genetic predisposition and clinical presentations: Established heritable causes and potential candidate genes | 1.3 | 23 | Citations (PDF) |
| 21 | Cancer worry among BRCA1/2 pathogenic variant carriers choosing surgery to prevent tubal/ovarian cancer: course over time and associated factors | 1.9 | 7 | Citations (PDF) |
| 22 | Risk of Peritoneal Carcinomatosis After Risk-Reducing Salpingo-Oophorectomy: A Systematic Review and Individual Patient Data Meta-Analysis | 17.2 | 93 | Citations (PDF) |
| 23 | Solving the genetic aetiology of hereditary gastrointestinal tumour syndromes– a collaborative multicentre endeavour within the project Solve-RD | 1.3 | 5 | Citations (PDF) |
| 24 | Healthcare professionals’ perspectives on implementation of universal tumor DNA testing in ovarian cancer patients: multidisciplinary focus groups | 1.3 | 6 | Citations (PDF) |
| 25 | Catch them if you are aware: postzygotic mosaicism in clinically suspicious patients with PTEN Hamartoma Tumour Syndrome and literature review | 1.3 | 12 | Citations (PDF) |
| 26 | The yield and effectiveness of breast cancer surveillance in women with PTEN Hamartoma Tumor Syndrome | 2.8 | 14 | Citations (PDF) |
| 27 | Detection and Yield of Colorectal Cancer Surveillance in Adults with PTEN Hamartoma Tumour Syndrome | 2.9 | 6 | Citations (PDF) |
| 28 | Noncoding Aberrations in Mismatch Repair Genes Underlie a Substantial Part of the Missing Heritability in Lynch Syndrome | 7.4 | 31 | Citations (PDF) |
| 29 | A review on age-related cancer risks in PTEN hamartoma tumor syndrome | 1.6 | 73 | Citations (PDF) |
| 30 | Somatic Nonepigenetic Mismatch Repair Gene Aberrations Underly Most Mismatch Repair–Deficient Lynch-Like Tumors | 7.4 | 13 | Citations (PDF) |
| 31 | No signs of subclinical atherosclerosis after risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers | 2.1 | 7 | Citations (PDF) |
| 32 | RNF43 mutation analysis in serrated polyposis, sporadic serrated polyps and Lynch syndrome polyps | 2.7 | 19 | Citations (PDF) |
| 33 | European Reference Networks: challenges and opportunities | 1.1 | 53 | Citations (PDF) |
| 34 | Breast cancer surveillance in women with PTEN Hamartoma Tumour Syndrome (PHTS) | 0.9 | 0 | Citations (PDF) |
| 35 | Challenges of Neoantigen Targeting in Lynch Syndrome and Constitutional Mismatch Repair Deficiency Syndrome | 2.9 | 9 | Citations (PDF) |
| 36 | A mosaic PIK3CA variant in a young adult with diffuse gastric cancer: case report | 2.4 | 10 | Citations (PDF) |
| 37 | Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study | 15.4 | 102 | Citations (PDF) |
| 38 | Association of Salpingectomy With Delayed Oophorectomy Versus Salpingo-oophorectomy With Quality of Life in BRCA1/2 Pathogenic Variant Carriers: A Nonrandomized Controlled Trial | 11.6 | 78 | Citations (PDF) |
| 39 | Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy | 2.4 | 5 | Citations (PDF) |
| 40 | Red flags for early recognition of adult patients with Hamartoma Tumour Syndrome | 1.3 | 19 | Citations (PDF) |
| 41 | Overview of hereditary breast and ovarian cancer (HBOC) guidelines across Europe | 1.3 | 56 | Citations (PDF) |
| 42 | Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition. | 3.4 | 62 | Citations (PDF) |
| 43 | Candidate Gene Discovery in Hereditary Colorectal Cancer and Polyposis Syndromes–Considerations for Future Studies | 3.3 | 13 | Citations (PDF) |
| 44 | Hereditary diffuse gastric cancer: updated clinical practice guidelines | 15.4 | 390 | Citations (PDF) |
| 45 | Monoallelic NTHL1 Loss-of-Function Variants and Risk of Polyposis and Colorectal Cancer. | 7.4 | 35 | Citations (PDF) |
| 46 | Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome | 2.4 | 135 | Citations (PDF) |
| 47 | Evaluation of yield and experiences of age-related molecular investigation for heritable and nonheritable causes of mismatch repair deficient colorectal cancer to identify Lynch syndrome | 2.9 | 28 | Citations (PDF) |
| 48 | Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Results from The BRCA1 and BRCA2 Cohort Consortium | 0.7 | 31 | Citations (PDF) |
| 49 | TRIM28 haploinsufficiency predisposes to Wilms tumor | 2.9 | 48 | Citations (PDF) |
| 50 | Effect of PTEN inactivating germline mutations on innate immune cell function and thyroid cancer-induced macrophages in patients with PTEN hamartoma tumor syndrome | 5.5 | 23 | Citations (PDF) |
| 51 | Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-BRCA1/2 breast cancer families | 2.4 | 39 | Citations (PDF) |
| 52 | Romidepsin suppresses monosodium urate crystal-induced cytokine production through upregulation of suppressor of cytokine signaling 1 expression | 3.1 | 40 | Citations (PDF) |
| 53 | Mutational Signature Analysis Reveals NTHL1 Deficiency to Cause a Multi-tumor Phenotype | 29.9 | 151 | Citations (PDF) |
| 54 | Cancer-related distress in unselected women with newly diagnosed breast or ovarian cancer undergoing BRCA1/2 testing without pretest genetic counseling | 1.5 | 7 | Citations (PDF) |
| 55 | Hamartoma Tumor Syndrome and Immune Dysregulation | 2.9 | 37 | Citations (PDF) |
| 56 | Microsatellite instability screening in colorectal adenomas to detect Lynch syndrome patients? A systematic review and meta-analysis | 2.4 | 33 | Citations (PDF) |
| 57 | High Yield of Pathogenic Germline Mutations Causative or Likely Causative of the Cancer Phenotype in Selected Children with Cancer | 4.8 | 62 | Citations (PDF) |
| 58 | A patient decision aid for risk-reducing surgery in premenopausal BRCA1/2 mutation carriers: Development process and pilot testing | 1.7 | 21 | Citations (PDF) |
| 59 | Peritoneal carcinomatosis after risk-reducing surgery in BRCA1/2 mutation carriers | 2.8 | 36 | Citations (PDF) |
| 60 | Self-compassion, physical fitness and climacteric symptoms in oophorectomized BRCA1/2 mutation carriers | 2.3 | 4 | Citations (PDF) |
| 61 | Outcomes of screening gastroscopy in first-degree relatives of patients fulfilling hereditary diffuse gastric cancer criteria | 1.4 | 25 | Citations (PDF) |
| 62 | High demoralization in a minority of oophorectomized BRCA1/2 mutation carriers influences quality of life | 1.5 | 7 | Citations (PDF) |
| 63 | Increasing awareness and knowledge of lifestyle recommendations for cancer prevention in Lynch syndrome carriers: Randomized controlled trial | 1.6 | 11 | Citations (PDF) |
| 64 | Influence of Risk Category and Screening Round on the Performance of an MR Imaging and Mammography Screening Program in Carriers of the BRCA Mutation and Other Women at Increased Risk | 7.2 | 66 | Citations (PDF) |
| 65 | NTHL1 and MUTYH polyposis syndromes: two sides of the same coin? | 3.4 | 77 | Citations (PDF) |
| 66 | Cancer Risks for PMS2-Associated Lynch Syndrome | 17.2 | 193 | Citations (PDF) |
| 67 | The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI | 3.7 | 42 | Citations (PDF) |
| 68 | An online self-test added to colorectal cancer screening can increase the effectiveness of familial cancer risk assessment without increasing distress | 1.6 | 2 | Citations (PDF) |
| 69 | Cancer prevention by aspirin in children with Constitutional Mismatch Repair Deficiency (CMMRD) | 2.4 | 22 | Citations (PDF) |
| 70 | Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes | 1.3 | 31 | Citations (PDF) |
| 71 | Online self-test identifies women at high familial breast cancer risk in population-based breast cancer screening without inducing anxiety or distress | 3.7 | 14 | Citations (PDF) |
| 72 | Surveillance of Women with the BRCA1 or BRCA2 Mutation by Using Biannual Automated Breast US, MR Imaging, and Mammography | 7.2 | 68 | Citations (PDF) |
| 73 | Lifestyle Risk Factors for Breast Cancer in BRCA1/2-Mutation Carriers Around Childbearing Age | 1.6 | 7 | Citations (PDF) |
| 74 | Unraveling genetic predisposition to familial or early onset gastric cancer using germline whole-exome sequencing | 2.4 | 37 | Citations (PDF) |
| 75 | Self-compassion and climacteric symptoms in postmenopausal BRCA1/2 mutation carriers | 2.3 | 0 | Citations (PDF) |
| 76 | Immunotherapy holds the key to cancer treatment and prevention in constitutional mismatch repair deficiency (CMMRD) syndrome | 7.0 | 54 | Citations (PDF) |
| 77 | Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas | 1.0 | 57 | Citations (PDF) |
| 78 | Colorectal Cancer Risk in Patients With Lynch Syndrome and Inflammatory Bowel Disease | 5.6 | 22 | Citations (PDF) |
| 79 | Determinants of adherence to recommendations for cancer prevention among Lynch Syndrome mutation carriers: A qualitative exploration | 1.6 | 13 | Citations (PDF) |
| 80 | Prevalence of germline mutations in the spindle assembly checkpoint gene BUB1B in individuals with early-onset colorectal cancer | 1.7 | 29 | Citations (PDF) |
| 81 | Opportunities for immunotherapy in microsatellite instable colorectal cancer | 3.4 | 97 | Citations (PDF) |
| 82 | Prospective Dutch colorectal cancer cohort: an infrastructure for long-term observational, prognostic, predictive and (randomized) intervention research | 1.5 | 94 | Citations (PDF) |
| 83 | Finding all BRCA pathogenic mutation carriers: best practice models | 2.4 | 16 | Citations (PDF) |
| 84 | Very high uptake of risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers: A single-center experience | 2.4 | 27 | Citations (PDF) |
| 85 | The genetic heterogeneity of colorectal cancer predisposition - guidelines for gene discovery | 3.5 | 30 | Citations (PDF) |
| 86 | Salpingectomy With Delayed Oophorectomy in BRCA1/2 Mutation Carriers | 2.9 | 19 | Citations (PDF) |
| 87 | Cardiovascular risk of BRCA1/2 mutation carriers: A review | 2.3 | 32 | Citations (PDF) |
| 88 | Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline | 1.6 | 165 | Citations (PDF) |
| 89 | Colorectal cancer risk variants at 8q23.3 and 11q23.1 are associated with disease phenotype in APC mutation carriers | 1.3 | 10 | Citations (PDF) |
| 90 | Recognition of genetic predisposition in pediatric cancer patients: An easy-to-use selection tool | 1.3 | 168 | Citations (PDF) |
| 91 | High Satisfaction and Low Distress in Breast Cancer Patients One Year after BRCA-Mutation Testing without Prior Face-to-Face Genetic Counseling | 1.6 | 28 | Citations (PDF) |
| 92 | Peer support and additional information in group medical consultations (GMCs) for BRCA1/2 mutation carriers: A randomized controlled trial | 1.5 | 6 | Citations (PDF) |
| 93 | Childhood neuroendocrine tumours: a descriptive study revealing clues for genetic predisposition | 4.5 | 25 | Citations (PDF) |
| 94 | Germline activating TYK2 mutations in pediatric patients with two primary acute lymphoblastic leukemia occurrences | 4.0 | 49 | Citations (PDF) |
| 95 | Identification of Novel Candidate Genes for Early-Onset Colorectal Cancer Susceptibility | 2.3 | 54 | Citations (PDF) |
| 96 | Deleterious Germline BLM Mutations and the Risk for Early-onset Colorectal Cancer | 2.8 | 71 | Citations (PDF) |
| 97 | Breast Self-examination Education for BRCA Mutation Carriers by Clinical Nurse Specialists | 0.5 | 12 | Citations (PDF) |
| 98 | Poor Prognosis of Constitutive γ-H2AX Expressing Triple-Negative Breast Cancers is Associated With Telomere Length | 1.1 | 16 | Citations (PDF) |
| 99 | Risk-reducing salpingectomy with delayed oophorectomy in BRCA1/2 mutation carriers: Patients' and professionals' perspectives | 2.4 | 47 | Citations (PDF) |
| 100 | Gastric cancer in three relatives of a patient with a biallelic IL12RB1 mutation | 1.3 | 19 | Citations (PDF) |
| 101 | Germline deletions in the tumour suppressor gene FOCAD are associated with polyposis and colorectal cancer development | 3.4 | 29 | Citations (PDF) |
| 102 | Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers | 2.4 | 475 | Citations (PDF) |
| 103 | Highlights from the seventh European Multidisciplinary Colorectal Cancer Congress (EMCCC) 2014. | 0.9 | 0 | Citations (PDF) |
| 104 | How medical choices influence quality of life of women carrying a mutation | 3.6 | 24 | Citations (PDF) |
| 105 | Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1 | 7.4 | 71 | Citations (PDF) |
| 106 | A germline homozygous mutation in the base-excision repair gene NTHL1 causes adenomatous polyposis and colorectal cancer | 14.9 | 331 | Citations (PDF) |
| 107 | Improving recognition and referral of patients with an increased familial risk of colorectal cancer: results from a randomized controlled trial | 1.6 | 14 | Citations (PDF) |
| 108 | Low prevalence of serrated polyposis syndrome in screening populations: a systematic review | 0.4 | 27 | Citations (PDF) |
| 109 | Patient experiences with gene panels based on exome sequencing in clinical diagnostics: high acceptance and low distress | 1.6 | 22 | Citations (PDF) |
| 110 | Recurrent candidiasis and early-onset gastric cancer in a patient with a genetically defined partial MYD88 defect | 1.3 | 15 | Citations (PDF) |
| 111 | BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study | 2.4 | 64 | Citations (PDF) |
| 112 | NTHL1 defines novel cancer syndrome. | 0.5 | 21 | Citations (PDF) |
| 113 | DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers | 2.3 | 44 | Citations (PDF) |
| 114 | Germline MUTYH gene mutations are not frequently found in unselected patients with papillary breast carcinoma | 1.5 | 4 | Citations (PDF) |
| 115 | A multiplex method for the detection of serum antibodies against in silico-predicted tumor antigens | 3.4 | 10 | Citations (PDF) |
| 116 | Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations | 2.4 | 79 | Citations (PDF) |
| 117 | Easy-to-use online referral test detects most patients with a high familial risk of colorectal cancer | 1.6 | 12 | Citations (PDF) |
| 118 | Relevance and efficacy of breast cancer screening in BRCA1 and BRCA2 mutation carriers above 60 years: A national cohort study | 2.9 | 10 | Citations (PDF) |
| 119 | Colorectal cancer risk variants on 11q23 and 15q13 are associated with unexplained adenomatous polyposis | 2.4 | 22 | Citations (PDF) |
| 120 | Somatic Mutations in MLH1 and MSH2 Are a Frequent Cause of Mismatch-Repair Deficiency in Lynch Syndrome-Like Tumors | 7.4 | 309 | Citations (PDF) |
| 121 | Fourfold increased detection of Lynch syndrome by raising age limit for tumour genetic testing from 50 to 70 years is cost-effective | 20.6 | 23 | Citations (PDF) |
| 122 | HNF4A immunohistochemistry facilitates distinction between primary and metastatic breast and gastric carcinoma | 1.9 | 27 | Citations (PDF) |
| 123 | mutation carriers are potentially at higher cardiovascular risk | 3.6 | 30 | Citations (PDF) |
| 124 | Germline Mutations in the Spindle Assembly Checkpoint Genes BUB1 and BUB3 Are Risk Factors for Colorectal Cancer | 7.4 | 81 | Citations (PDF) |
| 125 | Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging. | 3.4 | 59 | Citations (PDF) |
| 126 | Clinical utility gene card for: Hereditary diffuse gastric cancer (HDGC) | 2.4 | 23 | Citations (PDF) |
| 127 | Breast cancer size estimation with MRI in BRCA mutation carriers and other high risk patients | 2.2 | 16 | Citations (PDF) |
| 128 | Can we test for hereditary cancer at 18 years when we start surveillance at 25? Patient reported outcomes | 1.3 | 17 | Citations (PDF) |
| 129 | Familial colorectal cancer risk assessment needs improvement for more effective cancer prevention in relatives | 1.6 | 20 | Citations (PDF) |
| 130 | Identification of germline mutations in the cancer predisposing gene CDH1 in patients with orofacial clefts. | 2.2 | 58 | Citations (PDF) |
| 131 | Focusing on Patient Needs and Preferences May Improve Genetic Counseling for Colorectal Cancer | 1.6 | 12 | Citations (PDF) |
| 132 | Comparability versus statistical correctness | 2.2 | 1 | Citations (PDF) |
| 133 | More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling | 1.3 | 39 | Citations (PDF) |
| 134 | Added Value of Family History in Counseling About Risk of BRCA1/2 Mutation in Early-Onset Epithelial Ovarian Cancer | 2.4 | 3 | Citations (PDF) |
| 135 | Exome Sequencing of Germline DNA from Non-BRCA1/2 Familial Breast Cancer Cases Selected on the Basis of aCGH Tumor Profiling | 1.6 | 19 | Citations (PDF) |
| 136 | A Nonsynonymous Polymorphism in IRS1 Modifies Risk of Developing Breast and Ovarian Cancers in BRCA1 and Ovarian Cancer in BRCA2 Mutation Carriers | 0.7 | 23 | Citations (PDF) |
| 137 | Differences in Natural History between Breast Cancers in BRCA1 and BRCA2 Mutation Carriers and Effects of MRI Screening-MRISC, MARIBS, and Canadian Studies Combined | 0.7 | 84 | Citations (PDF) |
| 138 | Higher cytoplasmic and nuclear poly(ADP-ribose) polymerase expression in familial than in sporadic breast cancer | 1.9 | 5 | Citations (PDF) |
| 139 | Rare variants in XRCC2 as breast cancer susceptibility alleles | 2.4 | 41 | Citations (PDF) |
| 140 | Adequacy of family history taking in ovarian cancer patients: a population-based study | 1.3 | 13 | Citations (PDF) |
| 141 | Familial gastric cancer: detection of a hereditary cause helps to understand its etiology | 1.5 | 35 | Citations (PDF) |
| 142 | Familial gastric cancer: guidelines for diagnosis, treatment and periodic surveillance | 1.3 | 65 | Citations (PDF) |
| 143 | CDH1-related hereditary diffuse gastric cancer syndrome: Clinical variations and implications for counseling | 2.9 | 113 | Citations (PDF) |
| 144 | Psychological distress in newly diagnosed colorectal cancer patients following microsatellite instability testing for Lynch syndrome on the pathologist’s initiative | 1.3 | 19 | Citations (PDF) |
| 145 | Revertant Somatic Mosaicism by Mitotic Recombination in Dyskeratosis Congenita | 4.6 | 116 | Citations (PDF) |
| 146 | Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers† | 1.0 | 34 | Citations (PDF) |
| 147 | EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patients | 1.3 | 134 | Citations (PDF) |
| 148 | Young age and a positive family history of colorectal cancer are complementary selection criteria for the identification of Lynch syndrome | 3.7 | 10 | Citations (PDF) |
| 149 | Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening | 3.7 | 6 | Citations (PDF) |
| 150 | Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study | 15.4 | 250 | Citations (PDF) |
| 151 | Constitutive expression of γ-H2AX has prognostic relevance in triple negative breast cancer | 1.5 | 76 | Citations (PDF) |
| 152 | Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation | 2.4 | 164 | Citations (PDF) |
| 153 | Erfelijke darmkanker | 0.0 | 0 | Citations (PDF) |
| 154 | A non-BRCA1/2 hereditary breast cancer sub-group defined by aCGH profiling of genetically related patients | 1.9 | 15 | Citations (PDF) |
| 155 | Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers | 2.0 | 17 | Citations (PDF) |
| 156 | Recurrence and variability of germline EPCAM deletions in Lynch syndrome† | 1.0 | 139 | Citations (PDF) |
| 157 | Identification of candidate predisposing copy number variants in familial and early-onset colorectal cancer patients† | 2.9 | 62 | Citations (PDF) |
| 158 | Spindle-Assembly Checkpoint and Gastrointestinal Cancer | 25.2 | 11 | Citations (PDF) |
| 159 | Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers. | 2.2 | 34 | Citations (PDF) |
| 160 | Lynch Syndrome-Associated Extracolonic Tumors Are Rare in Two Extended Families With the SameEPCAMDeletion | 0.6 | 56 | Citations (PDF) |
| 161 | Electronic reminders for pathologists promote recognition of patients at risk for Lynch syndrome: cluster-randomised controlled trial | 1.9 | 19 | Citations (PDF) |
| 162 | EPCAM deletions and heritable MSH2 promoter methylation in Lynch syndrome | 1.6 | 0 | Citations (PDF) |
| 163 | The epigenetics of (hereditary) colorectal cancer | 1.6 | 27 | Citations (PDF) |
| 164 | Noonan syndrome, the SOS1 gene and embryonal rhabdomyosarcoma | 1.7 | 38 | Citations (PDF) |
| 165 | A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population | 14.9 | 281 | Citations (PDF) |
| 166 | Psychosocial impact of Von Hippel–Lindau disease: levels and sources of distress | 1.6 | 40 | Citations (PDF) |
| 167 | Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction | 4.5 | 167 | Citations (PDF) |
| 168 | Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers | 2.4 | 184 | Citations (PDF) |
| 169 | Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer | 2.3 | 77 | Citations (PDF) |
| 170 | TP53 germline mutation testing in 180 families suspected of Li–Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes | 2.4 | 270 | Citations (PDF) |
| 171 | Germline copy number variation and cancer risk | 2.4 | 104 | Citations (PDF) |
| 172 | Shortened time interval between colorectal cancer diagnosis and risk testing for hereditary colorectal cancer is not related to higher psychological distress | 1.3 | 6 | Citations (PDF) |
| 173 | Body weight and risk of breast cancer in BRCA1/2 mutation carriers | 1.9 | 64 | Citations (PDF) |
| 174 | A simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; BRCA1 and BRCA2 as an example | 2.3 | 61 | Citations (PDF) |
| 175 | The tumor suppressor gene FBXW7 is disrupted by a constitutional t(3;4)(q21;q31) in a patient with renal cell cancer | 1.6 | 29 | Citations (PDF) |
| 176 | Genetic testing for Lynch syndrome in the first year of colorectal cancer: a review of the psychological impact | 1.3 | 18 | Citations (PDF) |
| 177 | Improvement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndrome | 1.3 | 73 | Citations (PDF) |
| 178 | In Lynch syndrome adenomas, loss of mismatch repair proteins is related to an enhanced lymphocytic response | 2.7 | 26 | Citations (PDF) |
| 179 | Deficient mismatch repair system in patients with sporadic advanced colorectal cancer | 4.5 | 444 | Citations (PDF) |
| 180 | Chromosome 8q23.3 and 11q23.1 Variants Modify Colorectal Cancer Risk in Lynch Syndrome | 7.4 | 73 | Citations (PDF) |
| 181 | A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2genes based on cancer family history | 3.7 | 48 | Citations (PDF) |
| 182 | Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers | 1.9 | 78 | Citations (PDF) |
| 183 | Female BRCA mutation carriers with a preference for prophylactic mastectomy are more likely to participate an educational-support group and to proceed with the preferred intervention within 2 years | 1.3 | 19 | Citations (PDF) |
| 184 | Novel RUNX1 mutations in familial platelet disorder with enhanced risk for acute myeloid leukemia: clues for improved identification of the FPD/AML syndrome | 4.0 | 85 | Citations (PDF) |
| 185 | Most Patients with Colorectal Tumors at Young Age Do Not Visit a Cancer Genetics Clinic | 1.3 | 32 | Citations (PDF) |
| 186 | Tumor characteristics as an analytic tool for classifying genetic variants of uncertain clinical significance† | 1.0 | 55 | Citations (PDF) |
| 187 | Is early-onset microsatellite and chromosomally stable colorectal cancer a hallmark of a genetic susceptibility syndrome? | 2.9 | 11 | Citations (PDF) |
| 188 | Genome-wide linkage scan in Dutch hereditary non-BRCA1/2 breast cancer families identifies 9q21-22 as a putative breast cancer susceptibility locus | 1.7 | 15 | Citations (PDF) |
| 189 | Breast tumor characteristics of BRCA1 and BRCA2 gene mutation carriers on MRI | 3.2 | 70 | Citations (PDF) |
| 190 | The impact of a false-positive MRI on the choice for mastectomy in BRCA mutation carriers is limited | 20.6 | 35 | Citations (PDF) |
| 191 | Interpretation of Immunohistochemistry for Mismatch Repair Proteins is Only Reliable in a Specialized Setting | 2.4 | 121 | Citations (PDF) |
| 192 | Immunohistochemistry is not an accurate first step towards the molecular diagnosis of MUTYH-associated polyposis | 1.9 | 8 | Citations (PDF) |
| 193 | Incidence of cancer in first-degree relatives of basal cell carcinoma patients | 1.0 | 3 | Citations (PDF) |
| 194 | Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH | 1.9 | 142 | Citations (PDF) |
| 195 | Compound heterozygosity for two MSH2 mutations suggests mild consequences of the initiation codon variant c.1A>G of MSH2 | 2.4 | 20 | Citations (PDF) |
| 196 | Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1 | 14.9 | 724 | Citations (PDF) |
| 197 | Age at Menarche and Menopause and Breast Cancer Risk in the International BRCA1/2 Carrier Cohort Study | 0.7 | 69 | Citations (PDF) |
| 198 | Patients with an unexplained microsatellite instable tumour have a low risk of familial cancer | 4.5 | 42 | Citations (PDF) |
| 199 | Genomewide high-density SNP linkage analysis of non-BRCA1/2 breast cancer families identifies various candidate regions and has greater power than microsatellite studies | 2.2 | 25 | Citations (PDF) |
| 200 | Mapping of constitutional translocation breakpoints in renal cell cancer patients: identification of KCNIP4 as a candidate gene | 1.6 | 21 | Citations (PDF) |
| 201 | Optimizing the detection of hereditary non-polyposis colorectal cancer: An update | 1.1 | 4 | Citations (PDF) |
| 202 | Numerous high-risk epithelial lesions in familial breast cancer | 3.7 | 24 | Citations (PDF) |
| 203 | A substantial part of the fallopian tube is left after standard prophylactic bilateral salpingo-oophorectomy. | 2.4 | 10 | Citations (PDF) |
| 204 | Unfavorable pathological characteristics in familial colorectal cancer with low-level microsatellite instability | 3.9 | 10 | Citations (PDF) |
| 205 | Factors Affecting Sensitivity and Specificity of Screening Mammography and MRI in Women with an Inherited Risk for Breast Cancer | 1.9 | 82 | Citations (PDF) |
| 206 | A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic setting† | 1.0 | 73 | Citations (PDF) |
| 207 | Surveillance of women at high risk for hereditary ovarian cancer is inefficient | 4.5 | 93 | Citations (PDF) |
| 208 | Very low prevalence of germline MSH6 mutations in hereditary non-polyposis colorectal cancer suspected patients with colorectal cancer without microsatellite instability | 4.5 | 13 | Citations (PDF) |
| 209 | Optimal selection for BRCA1 and BRCA2 mutation testing using a combination of ‘easy to apply’ probability models | 4.5 | 12 | Citations (PDF) |
| 210 | Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer | 1.9 | 38 | Citations (PDF) |
| 211 | The decision evaluation scales | 1.4 | 54 | Citations (PDF) |
| 212 | Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients | 1.3 | 65 | Citations (PDF) |
| 213 | Randomized Trial of a Shared Decision-Making Intervention Consisting of Trade-Offs and Individualized Treatment Information for BRCA1/2 Mutation Carriers | 17.2 | 106 | Citations (PDF) |
| 214 | Current clinical selection strategies for identification of hereditary non-polyposis colorectal cancer families are inadequate: a meta-analysis | 1.6 | 59 | Citations (PDF) |
| 215 | Impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer | 1.1 | 64 | Citations (PDF) |
| 216 | More Differences Between HNPCC-related and Sporadic Carcinomas From the Endometrium as Compared to the Colon | 2.4 | 61 | Citations (PDF) |
| 217 | Very low incidence of microsatellite instability in rectal cancers from families at risk for HNPCC | 1.6 | 18 | Citations (PDF) |
| 218 | High Prevalence of Premalignant Lesions in Prophylactically Removed Breasts From Women at Hereditary Risk for Breast Cancer | 17.2 | 134 | Citations (PDF) |
| 219 | Atorvastatin, Diabetic Dyslipidemia, and Cognitive Functioning | 6.9 | 24 | Citations (PDF) |
| 220 | The effect of tibolone on the lipoprotein profile of postmenopausal women with type III hyperlipoproteinemia | 3.6 | 5 | Citations (PDF) |
| 221 | High fat intake in hyperlipidaemic patients is related to male gender, smoking, alcohol intake and obesity | 0.8 | 6 | Citations (PDF) |
| 222 | Corneal arcus: indicator for severity of coronary atherosclerosis? | 0.8 | 6 | Citations (PDF) |
| 223 | Atorvastatin increases low-density lipoprotein size and enhances high-density lipoprotein cholesterol concentration in male, but not in female patients with familial hypercholesterolemia | 1.9 | 43 | Citations (PDF) |
| 224 | Gemfibrozil decreases autoantibodies against oxidized low-density lipoprotein in men with combined hyperlipidaemia | 3.6 | 7 | Citations (PDF) |
| 225 | Effects of atorvastatin on serum lipids of patients with familial hypercholesterolaemia | 3.6 | 11 | Citations (PDF) |
| 226 | The IGF-I/IGFBP system in congenital partial lipodystrophy | 1.5 | 13 | Citations (PDF) |
| 227 | Estrogen replacement decreases the level of antibodies against oxidized low-density lipoprotein in postmenopausal women with coronary heart disease. | 9.3 | 30 | Citations (PDF) |
| 228 | Growth hormone restores hepatic lipase mRNA levels but the translation is impaired in hepatocytes of hypothyroid rats | 2.6 | 5 | Citations (PDF) |
| 229 | Significance of various parameters derived from biological variability of lipoprotein(a), homocysteine, cysteine, and total antioxidant status | 0.6 | 44 | Citations (PDF) |
| 230 | Transient hyperlipidemia during treatment of ALL with L-asparaginase is related to decreased lipoprotein lipase activity | 4.0 | 60 | Citations (PDF) |
| 231 | The additional effects of acipimox to simvastatin in the treatment of combined hyperlipidaemia | 3.6 | 19 | Citations (PDF) |
| 232 | Growth hormone normalizes low-density lipoprotein receptor gene expression in hypothyroid rats | 9.3 | 13 | Citations (PDF) |
| 233 | Hypertriglyceridemia Enhances Monocyte Binding to Endothelial Cells in NIDDM | 6.9 | 19 | Citations (PDF) |
| 234 | Lipoprotein(a) in Patients With Acute Cerebral Ischemia | 4.7 | 29 | Citations (PDF) |
| 235 | LETTERS TO THE EDITOR | 3.6 | 7 | Citations (PDF) |
| 236 | Performance of a Direct, Immunoseparation Based LDL-Cholesterol Method Compared to Friedewald Calculation and a Polyvinyl Sulphate Precipitation Method | 2.1 | 4 | Citations (PDF) |
| 237 | Monocytes from patients with combined hypercholesterolemia-hypertriglyceridemia and isolated hypercholesterolemia show an increased adhesion to endothelial cells in vitro: II. Influence of intrinsic and extrinsic factors on monocyte binding | 9.3 | 18 | Citations (PDF) |
| 238 | The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition | 1.5 | 271 | Citations (PDF) |
| 239 | The efficacy and safety of pravastatin, compared to and in combination with bile acid binding resins, in familial hypercholesterolaemia | 3.6 | 33 | Citations (PDF) |
| 240 | Experience in a PTEN Hamartoma Tumor Syndrome Expertise Centre: Yield of Thyroid Ultrasound Surveillance in Children with PTEN Hamartoma Tumor Syndrome | 0.9 | 6 | Citations (PDF) |
| 241 | CHEK2-associated tumour predisposition: a challenge in diagnostics and surveillance | 0.3 | 1 | Citations (PDF) |
| 242 | Prevention strategies for hereditary gynaecological cancer in Lynch syndrome | 1.3 | 0 | Citations (PDF) |
| 243 | Hereditary gynecological cancer management in women with Lynch syndrome: a survey across Europe. | 1.3 | 0 | Citations (PDF) |
| 244 | Genome Sequencing of Undiagnosed European Patients Suspected of Hereditary Cancer: Diagnostic Yield and Identification of Candidate Causative Variants. | 1.3 | 1 | Citations (PDF) |
| 245 | Personalized risk estimates of advanced neoplasia development in individuals with a family history of colorectal cancer. | 1.3 | 0 | Citations (PDF) |
| 246 | Hereditary cancer: Germline testing practices across ERN GENTURIS member countries. | 2.4 | 2 | Citations (PDF) |
| 247 | ERN GENTURIS cancer surveillance guideline for individuals with PTEN hamartoma tumour syndrome (PHTS). | 2.4 | 0 | Citations (PDF) |
| 248 | Opportunities to improve detection of genetic predisposition for ovarian cancer applying the Tumor-First workflow. | 1.3 | 0 | Citations (PDF) |
